Literature DB >> 34280061

Carbopol-olive oil-based bigel drug delivery system of doxycycline hyclate for the treatment of acne.

Kumud Soni1, Vishal Gour1, Poornima Agrawal1, Tanweer Haider1, Indu Lata Kanwar1, Avijit Bakshi1, Vandana Soni1.   

Abstract

OBJECTIVE: The objective of this study was to prepare and evaluate the doxycycline hyclate containing bigel for the effective treatment of acne.
METHODS: Bigels are biphasic systems formed by water-based hydrogels and oil-based organogel. Carbopol 940 was used to prepare the hydrogel phase, whereas Span-60 and olive oil for the oleogel phase.
RESULTS: The microstructure of bigel confirmed the oil in water type emulsion formation. The average droplet size of formulations was found 15-50 µm, and a bell-shaped droplet distribution curve, rheological, or viscosity studies suggested that the consistency and stability of bigel decrease with high organogel concentration. Three formulations (F1, F2, and F3) of the different ratios of hydrogel:oleogel (60:40, 70:30, and 80:20) were prepared in which F1 was less stable compared to F2 and F3. The drug content of F2 and F3 was respectively 79.94 and 71.33%. Formulation F2 was found more effective as compared to F3 based on in vitro drug release studies. Bigel also showed better results during in vivo studies at the rabbit ear model, which reduce acne diameter up to 1.10 mm from 4.9 mm while gel reduced it up to 1.20 mm.

Entities:  

Keywords:  Bigel; acne; carbopol 940; doxycycline hyclate; olive oil

Mesh:

Substances:

Year:  2021        PMID: 34280061     DOI: 10.1080/03639045.2021.1957916

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  1 in total

1.  Development of Bigels Based on Date Palm-Derived Cellulose Nanocrystal-Reinforced Guar Gum Hydrogel and Sesame Oil/Candelilla Wax Oleogel as Delivery Vehicles for Moxifloxacin.

Authors:  Hamid M Shaikh; Arfat Anis; Anesh Manjaly Poulose; Niyaz Ahamad Madhar; Saeed M Al-Zahrani
Journal:  Gels       Date:  2022-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.